Novartis (NVS) to Undertake Job Cuts in Development Department
https://www.zacks.com/stock/news/2253912/novartis-nvs-to-undertake-job-cuts-in-development-department?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253912
Apr 11, 2024 - Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
0
Agilent (A) is Set for Analytica 2024 With Advanced Products
https://www.zacks.com/stock/news/2252827/agilent-a-is-set-for-analytica-2024-with-advanced-products?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2252827
Apr 09, 2024 - Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
0
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
https://www.zacks.com/stock/news/2225655/incyte-s-incy-q4-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2225655
Feb 13, 2024 - Incyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross the $1 billion mark for the first time on the continued growth of Jakafi and the strong launch of Opzelura.
0
Here's What Key Metrics Tell Us About Incyte (INCY) Q4 Earnings
https://www.zacks.com/stock/news/2225440/here-s-what-key-metrics-tell-us-about-incyte-incy-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2225440
Feb 13, 2024 - The headline numbers for Incyte (INCY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Ahead of Incyte (INCY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2224024/ahead-of-incyte-incy-q4-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224024
Feb 09, 2024 - Evaluate the expected performance of Incyte (INCY) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
0
Pages: 1
Page 1